FDA Class II · Drug · May 13, 2026
NAPROXEN ORAL SUSPENSION recall — Acella Pharmaceuticals, LLC
Chemical contamination; presence of lead and lithium above specification
Official ID D-0523-2026 · Official record ↗
1 recent recall on record for Acella Pharmaceuticals in CPSC, NHTSA, and FDA data as of July 24, 2026 at 1:09 AM UTC.
Chemical contamination; presence of lead and lithium above specification
Official ID D-0523-2026 · Official record ↗
Found something wrong or missing? Report a data error.
Compiled from official public-domain government data. Last checked July 24, 2026 at 1:09 AM UTC.